Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma.
Duvic, Madeleine
Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma. [electronic resource] - Dermatologic clinics Oct 2015 - 757-64 p. digital
Publication Type: Journal Article; Review
1558-0520
10.1016/j.det.2015.05.010 doi
Depsipeptides--adverse effects
Histone Deacetylase Inhibitors--adverse effects
Humans
Hydroxamic Acids--adverse effects
Indoles--adverse effects
Lymphoma, T-Cell, Cutaneous--drug therapy
Panobinostat
Skin Neoplasms--drug therapy
Sulfonamides--adverse effects
Vorinostat
Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma. [electronic resource] - Dermatologic clinics Oct 2015 - 757-64 p. digital
Publication Type: Journal Article; Review
1558-0520
10.1016/j.det.2015.05.010 doi
Depsipeptides--adverse effects
Histone Deacetylase Inhibitors--adverse effects
Humans
Hydroxamic Acids--adverse effects
Indoles--adverse effects
Lymphoma, T-Cell, Cutaneous--drug therapy
Panobinostat
Skin Neoplasms--drug therapy
Sulfonamides--adverse effects
Vorinostat